Recruiting OBSERVATIONAL NCT07086014
Methamphetamine Cue-reactivity
Cue Reactivity Modulation in MSM With Methamphetamine Use Disorder
Sponsor: Icahn School of Medicine at Mount Sinai
Conditions
Methamphetamine Use Disorder
Interventions
Cognitive Reappraisal
Updated 1 time since 2025 Last updated: Jul 18, 2025 Started: Aug 19, 2024 Primary completion: Aug 30, 2025 Completion: Aug 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07086014, this observational or N/A phase trial focuses on Methamphetamine Use Disorder and remains actively recruiting participants. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Icahn School of Medicine at Mount Sinai
- National Institute on Drug Abuse (NIDA)
Data source: Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .